| 注册
首页|期刊导航|中国临床药理学杂志|浅谈mRNA疫苗的临床安全性及评价

浅谈mRNA疫苗的临床安全性及评价

刘琳玉 鲁爽

中国临床药理学杂志2026,Vol.42Issue(3):434-438,5.
中国临床药理学杂志2026,Vol.42Issue(3):434-438,5.DOI:10.13699/j.cnki.1001-6821.2026.03.021

浅谈mRNA疫苗的临床安全性及评价

A brief discussion on the clinical safety and evaluation of mRNA vaccines

刘琳玉 1鲁爽1

作者信息

  • 1. 国家药品监督管理局药品审评中心,北京,100076
  • 折叠

摘要

Abstract

Messenger ribonucleic acid(mRNA)vaccines represent a relatively new vaccine technology and have currently been applied to vaccine development across multiple infectious disease areas.To ensure the safety of participants,the safety evaluation of mRNA vaccines remains a key focus in current vaccine clinical research.This article discusses the safety assessment of preventive mRNA vaccines,drawing on clinical safety data and evaluations from currently marketed vaccines.

关键词

mRNA疫苗/2019冠状病毒病mRNA疫苗/呼吸道合胞病毒mRNA疫苗/安全性/安全性评价

Key words

mRNA vaccines/corona virus disease 2019 mRNA vaccines/respiratory syncytial virus mRNA vaccines/safety/safety evaluation

分类

医药卫生

引用本文复制引用

刘琳玉,鲁爽..浅谈mRNA疫苗的临床安全性及评价[J].中国临床药理学杂志,2026,42(3):434-438,5.

基金项目

药品监管科学全国重点实验室基金资助项目(2024SKLDRS0229) (2024SKLDRS0229)

中国临床药理学杂志

1001-6821

访问量0
|
下载量0
段落导航相关论文